Lloyd Diamond, CEO at Pixium Vision, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his company Pixium Vision’s amazing new retinal implant, developed in conjunction with Stanford- giving patients who are legally blind the gift of sight, (the technology offers those suffering from the dry form of age related macular degeneration the ability to regain their detailed central vision), allowing them to once again cook, take the right medications at the right time, pass vision tests they had failed in the past, and to see their grandchildren’s faces again; the value of offering this technology to elderly patients, how age is a mental state, not a number; the supportive ecosystem of the Passage de L’Innovation in Paris, and how Medtech investments function in France.
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
Specialties: C-Suite, Fundraising, Disruptive Technologies, Commercialization, P&L Management, Sales and Marketing, Operations in the Life Science sector
Specialties: C-Suite, Fundraising, Disruptive Technologies, Commercialization, P&L Management, Sales and Marketing, Operations in the Life Science sector
Lloyd Diamond, CEO at Pixium Vision, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his company Pixium Vision’s amazing new retinal implant, developed in conjunction with Stanford- giving patients who are legally blind the gift of sight, (the technology offers those suffering from the dry form of age related macular degeneration the ability to regain their detailed central vision), allowing them to once again cook, take the right medications at the right time, pass vision tests they had failed in the past, and to see their grandchildren’s faces again; the value of offering this technology to elderly patients, how age is a mental state, not a number; the supportive ecosystem of the Passage de L’Innovation in Paris, and how Medtech investments function in France.
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy